申请人:BRISTOL-MYERS SQUIBB COMPANY
公开号:US20210147408A1
公开(公告)日:2021-05-20
The present disclosure relates to compounds of formula I, which inhibit Gal-
3,
and include pharmaceutically acceptable salts, compositions comprising such compounds, and methods using and making such compounds and compositions.